United States - English - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - pantoprazole sodium (unii: 6871619q5x) (pantoprazole - unii:d8tst4o562) - pantoprazole 40 mg - pantoprazole sodium for injection is indicated for short-term treatment (7 to 10 days) of adult patients with gastroesophageal reflux disease (gerd) and a history of erosive esophagitis (ee). safety and efficacy of pantoprazole sodium for injection as a treatment of patients with gerd and a history of ee for more than 10 days have not been demonstrated. pantoprazole sodium for injection is indicated for the treatment of pathological hypersecretory conditions including zollinger-ellison (ze) syndrome in adults. •     pantoprazole sodium for injection is contraindicated in patients with known hypersensitivity reactions including anaphylaxis to the formulation or any substituted benzimidazole. hypersensitivity reactions may include anaphylaxis, anaphylactic shock, angioedema, bronchospasm, acute tubulointerstitial nephritis, and urticaria [see warnings and precautions (5.3), adverse reactions (6)] . •     proton pump inhibitors (ppis), including pantoprazole sodium for injection, are contraindicated in patients

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - pantoprazole sodium, quantity: 42.3 mg (equivalent: pantoprazole, qty 40 mg) - injection, powder for - excipient ingredients: nitrogen - short-term use where oral therapy is not appropriate for the following conditions. symptomatic improvement and healing of gastrointestinal diseases which require a reduction in acid secretion, e.g. duodenal ulcer, gastric ulcer, reflux oesophagitis, gastrointestinal lesions refractory to h2 blocker, zollinger-ellison syndrome. maintenance of healed reflux oesophagitis in patients previously treated for moderate to severe reflux oesophagitis. note. patients whose gastric or duodenal ulceration is not associated with ingestion of nonsteroidal anti-inflammatory drugs require treatment with antimicrobial agents in addition to antisecretory drugs, whether on first presentation or recurrence.

United States - English - NLM (National Library of Medicine)

unit dose services - pantoprazole sodium (unii: 6871619q5x) (pantoprazole - unii:d8tst4o562) - pantoprazole 20 mg - pantoprazole sodium delayed-release tablets are indicated for: pantoprazole sodium delayed-release tablet is indicated in adults and pediatric patients five years of age and older for the short-term treatment (up to 8 weeks) in the healing and symptomatic relief of erosive esophagitis (ee). for those adult patients who have not healed after 8 weeks of treatment, an additional 8-week course of pantoprazole sodium delayed-release tablets may be considered. safety of treatment beyond 8 weeks in pediatric patients has not been established. pantoprazole sodium delayed-release tablets are indicated for maintenance of healing of ee and reduction in relapse rates of daytime and nighttime heartburn symptoms in adult patients with gerd. controlled studies did not extend beyond 12 months. pantoprazole sodium delayed-release tablets are indicated for the long-term treatment of pathological hypersecretory conditions, including zollinger-ellison (ze) syndrome. •  pantoprazole sodium delayed-release tablets are contraindica

Canada - English - Health Canada

mylan pharmaceuticals ulc - pantoprazole (pantoprazole sodium sesquihydrate) - powder for solution - 40mg - pantoprazole (pantoprazole sodium sesquihydrate) 40mg - proton-pump inhibitors

Malta - English - Medicines Authority

mylan ireland limited unit 35/36, grange parade, baldoyle industrial estate, dublin 13, ireland - pantoprazole - gastro-resistant tablet - pantoprazole 20 mg - drugs for acid related disorders

Canada - English - Health Canada

meliapharm inc - pantoprazole (pantoprazole sodium) - tablet (delayed-release) - 20mg - pantoprazole (pantoprazole sodium) 20mg - proton-pump inhibitors

Canada - English - Health Canada

meliapharm inc - pantoprazole (pantoprazole sodium) - tablet (delayed-release) - 40mg - pantoprazole (pantoprazole sodium) 40mg - proton-pump inhibitors

Canada - English - Health Canada

sorres pharma inc - pantoprazole (pantoprazole sodium) - tablet (delayed-release) - 40mg - pantoprazole (pantoprazole sodium) 40mg - proton-pump inhibitors

Canada - English - Health Canada

teva canada limited - pantoprazole (pantoprazole sodium sesquihydrate) - powder for solution - 40mg - pantoprazole (pantoprazole sodium sesquihydrate) 40mg - proton-pump inhibitors

Canada - English - Health Canada

laboratoire riva inc. - pantoprazole (pantoprazole sodium sesquihydrate) - tablet (delayed-release) - 20mg - pantoprazole (pantoprazole sodium sesquihydrate) 20mg - proton-pump inhibitors